- Report
- September 2024
- 135 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- May 2024
- 130 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- May 2024
- 129 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- May 2024
- 133 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- May 2024
- 128 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- May 2024
- 137 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- May 2024
- 140 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- May 2024
- 139 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- May 2024
- 128 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- May 2024
- 134 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- May 2024
- 139 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- May 2024
- 134 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- May 2024
- 140 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- May 2024
- 129 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- January 2025
- 140 Pages
Global
From €3595EUR$3,950USD£3,054GBP
- Report
- December 2024
- 144 Pages
Global
From €3595EUR$3,950USD£3,054GBP
- Report
- January 2025
- 185 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Report
- April 2025
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- April 2025
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more